S. Sherman, et al. Design and Development of LNP Targeting Ligands for In Vivo Hematopoietic Stem Cell Editing. Presented at the American Society of Gene and Cell Therapy (ASGCT). May 13 – 17, 2025.

Mar

9

Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates

Feb

23

Editas Medicine to Participate in Upcoming Investor Conferences

Nov

10

Editas Medicine Announces Third Quarter 2025 Results and Business Updates